Login to Your Account



MDRNA Wins FDA OK for Calcitonin in Osteo

By Catherine Hollingsworth


Wednesday, June 10, 2009
MDRNA Inc. is making good on its plan to maximize its shelved nasal programs, with the FDA's approval of a generic nasal spray for osteoporosis that has been launched by Par Pharmaceutical Cos. Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription